{
  "docId": "019de517-75a1-7387-968b-d0dc513bf421",
  "docSlug": "e930bfcc8684afb6f5a4dd5442b5166d",
  "documentTitle": "Ocuphire Pharma | Investor Presentation Deck | 42 slides",
  "authorId": "ocuphire-pharma",
  "authorName": "Ocuphire Pharma",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 28,
  "pageCount": 42,
  "prevPage": 27,
  "nextPage": 29,
  "slideType": "solution",
  "function": "present_solution",
  "density": "overcrowded",
  "nDataPoints": 8,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de517-75a1-7387-968b-d0dc513bf421/28",
  "deckHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421",
  "deckJsonHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421.json",
  "deckAnchorHref": "/decks/019de517-75a1-7387-968b-d0dc513bf421#slide-28",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.299,
        "x": 0.57,
        "y": 0.73
      },
      "kind": "callout",
      "text": "BCVA data shows fewer APX3330 treated subjects losing visual acuity compared to placebo at week 24",
      "attrs": {},
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "25afbb81-4fa4-4cc0-a5e1-23bb27f8867f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.309,
        "x": 0.15,
        "y": 0.73
      },
      "kind": "callout",
      "text": "APX3330 reduced the percentage of subjects who developed PDR over the course of 24 weeks",
      "attrs": {},
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "32b30887-3e07-4021-89b9-f8ba2b549ffd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.502,
        "w": 0.299,
        "x": 0.57,
        "y": 0.18
      },
      "kind": "chart",
      "text": "Percentage of Subjects with ≥ 5 Letters of BCVA Lost at Week 24 (Safety Population)\n% of Subjects\n19%\np=0.07\n5%\nPlacebo (n=43)\nAPX3330 (n=40)\nTreatment Group",
      "attrs": {},
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8dfaca0f-6ea0-4dd7-ab93-97969ff19358",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.502,
        "w": 0.302,
        "x": 0.159,
        "y": 0.18
      },
      "kind": "chart",
      "text": "Percentage of Subjects Developing PDR (mITT Population) at week 24\nSubjects Developing PDR (%)\n24%\np=0.22\n14%\nPlacebo (n=50)\nAPX 3330 (n=48)\nTreatment Group",
      "attrs": {},
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "934af096-3845-4c84-a2d4-07174b41ea87",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.026,
        "w": 0.084,
        "x": 0.025,
        "y": 0.935
      },
      "kind": "image",
      "text": "Ocuphire",
      "attrs": {},
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "319114cc-1c44-4d8d-b9f5-1e9d68ccc389",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.013,
        "w": 0.103,
        "x": 0.118,
        "y": 0.943
      },
      "kind": "source-note",
      "text": "ZETA-1 Clinical Trial.",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "65ffa993-bba8-446a-906e-0ddc2ed5e4b4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.016,
        "w": 0.64,
        "x": 0.047,
        "y": 0.102
      },
      "kind": "title",
      "text": "APX3330 Prevented Progression of Structural Retinal Abnormalities",
      "attrs": {},
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4e70f2c6-247b-4d05-a4b8-37870c1cdd35",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.87,
        "x": 0.047,
        "y": 0.06
      },
      "kind": "title",
      "text": "APX3330 Reduced % of Subjects Developing PDR and % Losing BCVA",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bd27f78f-fe0c-4845-832b-7e7a05e2c87d",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Waterfall chart",
      "slug": "waterfall-chart",
      "agent": null,
      "layer": "slide",
      "matchId": "c53a956e-2941-463e-b135-bd5ef9cdcc1c",
      "evidence": "chart/bar-vertical: Percentage of Subjects with ≥ 5 Letters of BCVA Lost at Week 24 (Safety Population)",
      "confidence": 0.8
    },
    {
      "name": "Waterfall chart",
      "slug": "waterfall-chart",
      "agent": null,
      "layer": "slide",
      "matchId": "6560da42-69b8-4b33-949c-886fe873c93e",
      "evidence": "chart/bar-vertical: Percentage of Subjects Developing PDR (mITT Population) at week 24",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 28,
      "from": 17,
      "beatId": "65814d93-901f-41c1-8ee8-b0d5c8ea9369",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Evidence & Proof",
      "beatSlug": "consultants-gambit-evidence-proof",
      "evidence": "Slides 17-28 provide clinical trial results and data for APX3330",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}